S&P 500 Futures
(0.66%) 5 079.75 points
Dow Jones Futures
(0.46%) 38 243 points
Nasdaq Futures
(0.83%) 17 583 points
Oil
(0.92%) $79.73
Gas
(2.38%) $1.978
Gold
(-0.03%) $2 310.20
Silver
(-0.89%) $26.51
Platinum
(0.80%) $962.50
USD/EUR
(0.23%) $0.935
USD/NOK
(0.36%) $11.07
USD/GBP
(0.12%) $0.799
USD/RUB
(-1.81%) $91.57

Обновления в реальном времени для Smith & Nephew plc [SN.L]

Биржа: LSE Промышленность: Medical Devices
Последнее обновление2 май 2024 @ 15:15

1.09% £ 987.20

Live Chart Being Loaded With Signals

Commentary (2 май 2024 @ 15:15):

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures...

Stats
Объем за сегодня 720 330
Средний объем 3.69M
Рыночная капитализация 8.63B
EPS £0 ( 2024-05-01 )
Дата следующего отчета о доходах ( £0 ) 2024-08-01
Last Dividend £18.38 ( 2023-03-30 )
Next Dividend £0 ( N/A )
P/E 41.13
ATR14 £0.613 (0.06%)

Объем Корреляция

Длинно: 0.21 (neutral)
Кратко: -0.55 (weak negative)
Signal:(54.798) Neutral

Smith & Nephew plc Корреляция

10 Самые положительные корреляции
10 Самые отрицательные корреляции

Вы знали?

Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).

Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.

Smith & Nephew plc Корреляция - Валюта/Сырье

The country flag -0.40
( neutral )
The country flag -0.59
( weak negative )
The country flag 0.57
( weak )
The country flag -0.59
( weak negative )
The country flag 0.38
( neutral )
The country flag 0.54
( weak )

Smith & Nephew plc Финансовые показатели

Annual 2023
Выручка: £5.55B
Валовая прибыль: £3.82B (68.82 %)
EPS: £0.300
FY 2023
Выручка: £5.55B
Валовая прибыль: £3.82B (68.82 %)
EPS: £0.300
FY 2022
Выручка: £5.22B
Валовая прибыль: £3.68B (70.47 %)
EPS: £0.250
FY 2021
Выручка: £5.21B
Валовая прибыль: £3.67B (70.40 %)
EPS: £0.598

Financial Reports:

No articles found.

Smith & Nephew plc Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
£12.91
(N/A)
£0
(N/A)
£18.38
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)

Smith & Nephew plc Dividend Information - Dividend Knight

Dividend Sustainability Score: 8.49 - good (84.92%) | Divividend Growth Potential Score: 6.49 - Stable (29.72%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend £3.45 1993-05-10
Last Dividend £18.38 2023-03-30
Next Dividend £0 N/A
Payout Date 2023-05-17
Next Payout Date N/A
# dividends 64 --
Total Paid Out £440.59 --
Avg. Dividend % Per Year 1.26% --
Score 4.39 --
Div. Sustainability Score 8.49
Div.Growth Potential Score 6.49
Div. Directional Score 7.49 --
Next Divdend (Est)
(2024-06-18)
£0 Estimate 1.28 %
Dividend Stability
0.10 Bad
Dividend Score
4.39
Pay Frequency
Semi-Annually
Yearly Payout
Year Amount Yield
1993 £0 0.00%
1994 £0 0.00%
1995 £0 0.00%
1996 £0 0.00%
1997 £0 0.00%
1998 £0 0.00%
1999 £0 0.00%
2000 £0 0.00%
2001 £0 0.00%
2002 £0 0.00%
2003 £0 0.00%
2004 £0 0.00%
2005 £0 0.00%
2006 £0 0.00%
2007 £0 0.00%
2008 £0 0.00%
2009 £0 0.00%
2010 £0 0.00%
2011 £0 0.00%
2012 £0 0.00%
2013 £0 0.00%
2014 £0 0.00%
2015 £0 0.00%
2016 £0 0.00%
2017 £0 0.00%
2018 £26.91 1.93%
2019 £28.49 1.99%
2020 £29.73 1.62%
2021 £27.12 1.73%
2022 £31.31 2.40%
2023 £18.38 1.64%
2024 £0 0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for LSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
PCFT.L Dividend Knight 2023-08-03 Semi-Annually 11 1.80%
FEVR.L Dividend Knight 2023-09-28 Semi-Annually 10 0.75%
AA4.L Dividend King 2023-07-13 Semi-Annually 9 7.97%
TAM.L Dividend Knight 2023-07-06 Semi-Annually 8 1.85%
KNM.L Dividend Knight 2023-09-28 Annually 14 0.97%
CFYN.L Dividend Knight 2023-07-13 Annually 33 1.92%
RCN.L Ex Dividend Junior 2023-12-07 Annually 11 1.07%
GNS.L Dividend Knight 2023-11-09 Semi-Annually 24 0.38%
APAX.L Dividend Knight 2023-09-14 Semi-Annually 9 3.81%
TRIG.L Dividend Knight 2023-08-10 Quarterly 11 3.09%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.04741.5009.0510.00[0 - 0.5]
returnOnAssetsTTM0.02631.2009.1210.00[0 - 0.3]
returnOnEquityTTM0.05031.500-0.552-0.828[0.1 - 1]
payoutRatioTTM1.243-1.00010.00-10.00[0 - 1]
currentRatioTTM1.7750.8006.134.90[1 - 3]
quickRatioTTM0.5690.800-1.359-1.087[0.8 - 2.5]
cashRatioTTM0.1331.500-0.372-0.558[0.2 - 2]
debtRatioTTM0.309-1.5004.85-7.28[0 - 0.6]
interestCoverageTTM01.000-1.111-1.111[3 - 30]
operatingCashFlowPerShareTTM0.6952.009.7710.00[0 - 30]
freeCashFlowPerShareTTM0.2072.009.9010.00[0 - 20]
debtEquityRatioTTM0.591-1.5007.64-10.00[0 - 2.5]
grossProfitMarginTTM0.7011.0001.6441.644[0.2 - 0.8]
operatingProfitMarginTTM0.1231.0009.549.54[0.1 - 0.6]
cashFlowToDebtRatioTTM0.1971.000-0.0159-0.0159[0.2 - 2]
assetTurnoverTTM0.5560.8009.637.70[0.5 - 2]
Total Score8.49

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM40.731.0005.990[1 - 100]
returnOnEquityTTM0.05032.50-0.355-0.828[0.1 - 1.5]
freeCashFlowPerShareTTM0.2072.009.9310.00[0 - 30]
dividendYielPercentageTTM2.861.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM0.6952.009.7710.00[0 - 30]
payoutRatioTTM1.2431.50010.00-10.00[0 - 1]
pegRatioTTM139.731.50010.000[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1101.0009.760[0.1 - 0.5]
Total Score6.49

Smith & Nephew plc

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

О Торговые сигналы

Данные торговые сигналы, представленные на этой странице, помогают определить, когда следует ПОКУПАТЬ или ПРОДАВАТЬ NA. Сигналы имеют задержку более 1 минуты. Пожалуйста, примите во внимание, что существует вероятность ошибки или неточностей в силу различных микро и макро факторов влияющих на фондовые рынки.

Данные тор“о”ые сигна“ы не являются определен“ыми, и getagraph.com не несет ответственности за какие-либо действия, предпринятые в от“ошении этих сигналов, как описано в Terms of Use. Сигналы основаны на широком спектре индикаторов технического анализа